Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
26.07
|
|
Change (%)
|
-0.06 (-0.23%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
24.83
-
27.43
|
|
52-Week Range (RS)
|
10.65
-
61.80
|
|
Beta (1 Year)
|
0.21
|
|
|
|
|
|
| News |
|
Corporate Details |
| Bacil Pharma to conduct AGM |
| Bacil Pharma announces board meeting date |
| Bacil Pharma to convene board meeting |
| Bacil Pharma reports standalone net loss of Rs 0.02 crore in the June 2026 quarter |
| Bacil Pharma announces board meeting date |
| Bacil Pharma to convene board meeting |
| Bacil Pharma to convene board meeting |
| Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter |
| Bacil Pharma to conduct board meeting |
|
|
|
| Incoporation Year : 1987 |
| Chairman : |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs |
| Registered Office |
Bacil Pharma Ltd
G2 & G3 Samarpan Complex,
chakala Andheri East,
Mumbai,
Maharashtra-400099 |
Phone:
Fax: |
| E-Mail : bacilpha@yahoo.com |
| URL : http://www.bacilpharma.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Sep-2026 |
23.95 |
8.85 |
| 1Month |
31-Aug-2026 |
12.60 |
106.90 |
| 3Month |
30-Jun-2026 |
39.99 |
-34.81 |
| 6Month |
30-Mar-2026 |
47.73 |
-45.38 |
| 1Year |
30-Sep-2025 |
42.87 |
-39.19 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Divis Laboratories Ltd |
9,282.00 |
-2.04 |
10,000.00 |
5,648.00 |
246,407.94 |
| Neuland Laboratories Ltd |
21,392.65 |
-0.01 |
24,235.05 |
11,500.00 |
27,446.53 |
| Acutaas Chemicals Ltd |
3,279.15 |
-0.71 |
3,735.00 |
1,290.05 |
26,846.77 |
| Jubilant Pharmova Ltd |
1,028.85 |
-1.99 |
1,183.90 |
783.75 |
16,389.58 |
| Gujarat Themis Biosyn Ltd |
387.75 |
-4.12 |
479.45 |
225.75 |
5,046.63 |
|
|
|
|